T40.902D Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter

Summary

This ICD code describes a subsequent encounter for intentional self-harm resulting from poisoning by unspecified psychodysleptics (hallucinogens). It applies to cases where exposure to these substances—known for altering perception, mood, or consciousness—is deliberate and causes harm, and the patient is receiving follow-up care after the initial encounter. The code is used when the specific hallucinogen is not identified, and the event is classified as intentional self-harm.

Causes

Intentional self-harm may occur from deliberate ingestion of hallucinogens, often in the context of suicidal ideation or attempts. Adverse effects can arise during recreational or intentional use, such as overdose or toxic reactions. The focus is on self-inflicted harm rather than accidental exposure or therapeutic use.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety).
• Prior suicide attempts or ideation.
• Access to hallucinogens.
• Concurrent substance use or misuse.
• Social or environmental stressors.

Symptoms

• Hallucinations, perceptual distortions, or sensory changes.
• Anxiety, paranoia, or disorientation.
• Nausea, vomiting, or dizziness.
• Increased heart rate or blood pressure.
• Altered mental status, including confusion or agitation.
• Potential for self-injurious behavior.

Diagnosis

Diagnosis relies on clinical evaluation, patient history (including substance use and intent), and assessment of symptoms. Toxicology screening may be used to identify the specific substance involved, though the code applies when the hallucinogen is unspecified. Documentation must confirm intentional self-harm and subsequent encounter status.

Treatment Options

Treatment focuses on managing acute symptoms, ensuring patient safety, and addressing underlying mental health concerns. Interventions may include supportive care, monitoring for complications, and referral to mental health services. The approach depends on the severity of poisoning and the patient’s clinical status.

Prognosis and Follow-Up

Prognosis varies based on the extent of poisoning, comorbidities, and access to care. Follow-up care is critical to address mental health needs and reduce the risk of recurrence. Ongoing monitoring and support can improve outcomes for patients with intentional self-harm.

Complications

• Severe psychological distress or trauma.
• Organ damage from toxic effects.
• Increased risk of future self-harm or suicide.
• Long-term cognitive or psychiatric sequelae.

Lifestyle & Prevention

• Secure storage of substances to limit access.
• Mental health support and therapy for at-risk individuals.
• Education on the risks of substance misuse.
• Building coping strategies for stress or emotional distress.

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms of poisoning (e.g., altered mental status, severe distress) are present. Ongoing mental health support is recommended for individuals with a history of intentional self-harm.

Tips for Medical Coders

Use this code for subsequent encounters related to intentional self-harm from unspecified psychodysleptics (hallucinogens). Ensure documentation confirms the intentional nature of the self-harm, the unspecified hallucinogen, and the subsequent encounter status. Verify that the encounter is not the initial episode of care.